Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Absci Corporation Common Stock
ABSI | US
3.94
USD-0.03
-0.76%
ABSI | US
Loading StockChartView...
About Absci Corporation Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
3.94
Open
3.97
High
4.02
Low
3.85
Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver Washington.
View LessABSI | US
Risk
73.9
Sharpe
0.21
Luna's Score
37/100
Recommendation
Sell
Luna says (ABSI | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Weakness based on declining price with high volume
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
80.4%1 month
73.9%3 months
85.6%6 months
88.1%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.12
Debt to equity
0.06
Debt to assets
0.05
Ent. to EBITDA
-0.39
Ent. to rev.
103.72
PEG
-
Other Fundamentals
EBITDA
-83.96M
MarketCap
447.41M
MarketCap(USD)
447.41M
Div. yield
-
Op. margin
-2.10K
Erngs. growth
-
Rev. growth
-62.30
Ret. on equity
-42.24
Short ratio
14.49
Short perc.
17.41
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.28
Range1M
1.44
Range3M
1.91
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.04
Price X volume
17.27M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.39 | 0.53 | Cheaper |
| Ent. to Revenue | 103.72 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.12 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 85.58 | 72.80 | Par |
| Debt to Equity | 0.06 | -1.23 | Expensive |
| Debt to Assets | 0.05 | 0.25 | Cheaper |
| Market Cap | 447.41M | 3.66B | Emerging |
